Causeway Capital Management LLC holds a focused book of 107 stocks worth $8.1B as of Q1 2026 (disclosed May 14, 2026, a ~45-day 13F lag). This quarter they opened AstraZeneca PLC and trimmed Canadian Pacific Kansas City. Their largest long position is AstraZeneca PLC at 18% of the equity book. Cloning the disclosed picks since 2013 would be +315% (+11.9%/yr). That is a simulation of the disclosed long book, not audited returns.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1165797/holdings"
Use Arkolith to show CAUSEWAY CAPITAL MANAGEMENT LLC's latest holdings, largest changes, and filing provenance.
The reported book (valued from quarter-end) returned +363.1%, a 48.4-point gap that is the cost of the ~45-day 13F disclosure lag a real follower can't avoid.
Growth of $10,000 cloning Causeway Capital Management LLC's disclosed long 13F book, rebalanced on each filing date (so it reflects the ~45-day reporting lag, no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.
Top-heavy: focused book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
87% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Other tracked managers holding the same core names as Causeway Capital Management LLC
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| MORGAN STANLEY | 80 / 80 | $101.0B |
| BANK OF AMERICA CORP /DE/ | 80 / 80 | $78.0B |
| GOLDMAN SACHS GROUP INC | 80 / 80 | $52.7B |
| ROYAL BANK OF CANADA | 80 / 80 | $38.8B |
| UBS Group AG | 80 / 80 | $34.6B |
| CITIGROUP INC | 80 / 80 | $11.5B |
| OSAIC HOLDINGS, INC. | 80 / 80 | $2.3B |
| BlackRock, Inc. | 79 / 80 | $398.9B |
Ranked by how many of Causeway Capital Management LLC's top 80 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | AstraZeneca PLC SPONSORED ADR | $1.4B | 7.42M | 17.7% | ▲New New position | |
| 2 | Carnival Corp UNIT 99/99/9999 | $960.1M | 37.10M | 11.8% | ▲+9.3% Added · +3.2M sh | |
| 3 | Deutsche Bank AG NAMEN AKT | $723.3M | 24.96M | 8.9% | ▲+76% Added · +10.8M sh | |
| 4 | Canadian Pacific Kansas City Ltd COM | $689.9M | 8.79M | 8.5% | ▼−30% Reduced · −3.8M sh | |
| 5 | Smurfit Westrock PLC SHS | $620.3M | 15.57M | 7.6% | ▼−19% Reduced · −3.6M sh | |
| 6 | Taiwan Semiconductor Manufacturing Co Ltd SPONSORED ADS | $171.8M | 508.5K | 2.1% | ▼−0.6% Reduced · −3K sh | |
| 7 | Alibaba Group Holding Ltd SPONSORED ADS | $134.1M | 1.07M | 1.6% | ▼−11% Reduced · −134K sh | |
| 8 | Carrier Global Corp COM | $118.4M | 2.10M | 1.5% | ▲+14% Added · +254K sh | |
| 9 | Merck & Co Inc COM | $102.8M | 854.2K | 1.3% | ▼−18% Reduced · −190K sh | |
| 10 | Alphabet Inc CAP STK CL C | $96.8M | 337.3K | 1.2% | ▼−8.8% Reduced · −33K sh | |
| 11 | Cognizant Technology Solutions Corp CL A | $92.3M | 1.50M | 1.1% | ▼−3.1% Reduced · −48K sh | |
| 12 | Alaska Air Group Inc COM | $92.0M | 2.50M | 1.1% | ▲+74% Added · +1.1M sh | |
| 13 | Anglogold Ashanti PLC COM SHS | $86.2M | 898.8K | 1.1% | ▲+107% Added · +465K sh | |
| 14 | Barclays PLC ADR | $86.2M | 4.07M | 1.1% | ▲+8.6% Added · +323K sh | |
| 15 | Credicorp Ltd COM | $83.1M | 245.1K | 1.0% | ▲+1.3% Added · +3K sh | |
| 16 | Meta Platforms Inc CL A | $82.8M | 144.8K | 1.0% | ▲+31% Added · +34K sh | |
| 17 | Axis Capital Holdings Ltd SHS | $82.7M | 815.8K | 1.0% | ▲+13% Added · +95K sh | |
| 18 | Everest Group Ltd COM | $81.7M | 250.0K | 1.0% | ▲+4.8% Added · +11K sh | |
| 19 | Live Nation Entertainment Inc COM | $80.3M | 526.4K | 1.0% | ▲+18% Added · +79K sh | |
| 20 | Sap SE SPON ADR | $78.1M | 456.0K | 1.0% | ▲+82% Added · +205K sh | |
| 21 | Relx PLC SPONSORED ADR | $76.5M | 2.31M | 0.9% | ▲+94% Added · +1.1M sh | |
| 22 | Gold Fields Ltd SPONSORED ADR | $74.2M | 1.63M | 0.9% | ▲+0.8% Added · +13K sh | |
| 23 | Zimmer Biomet Holdings Inc COM | $73.1M | 808.1K | 0.9% | ▲+11% Added · +80K sh | |
| 24 | Genpact Ltd SHS | $72.6M | 1.95M | 0.9% | ▼−6.5% Reduced · −136K sh | |
| 25 | Citigroup Inc COM NEW | $72.0M | 634.9K | 0.9% | ▼−9.0% Reduced · −63K sh | |
| 26 | Koninklijke Philips NV NY REGIS SHS NEW | $67.3M | 2.46M | 0.8% | ▲+12% Added · +258K sh | |
| 27 | Booz Allen Hamilton Holding Corp CL A | $66.9M | 857.5K | 0.8% | ▲+116% Added · +461K sh | |
| 28 | Whirlpool Corp COM | $64.8M | 1.20M | 0.8% | ▲+58% Added · +441K sh | |
| 29 | Analog Devices Inc COM | $64.2M | 201.8K | 0.8% | ▼−23% Reduced · −61K sh | |
| 30 | Citizens Financial Group Inc COM | $62.9M | 1.05M | 0.8% | ▲+3.4% Added · +34K sh | |
| 31 | Boeing Co COM | $62.5M | 313.9K | 0.8% | ▲+107% Added · +162K sh | |
| 32 | Jones Lang Lasalle Inc COM | $56.7M | 186.3K | 0.7% | ▲+213% Added · +127K sh | |
| 33 | Walt Disney Co COM | $54.0M | 559.9K | 0.7% | ▲+2.5% Added · +14K sh | |
| 34 | Pfizer Inc COM | $53.8M | 1.91M | 0.7% | ▼−8.5% Reduced · −178K sh | |
| 35 | Biogen Inc COM | $51.5M | 280.8K | 0.6% | ▼−46% Reduced · −240K sh | |
| 36 | Sanofi Sa SPONSORED ADR | $51.3M | 1.06M | 0.6% | ▲+0.1% Added · +558 sh | |
| 37 | Ingersoll Rand Inc COM | $50.2M | 626.1K | 0.6% | ▲+4.9% Added · +29K sh | |
| 38 | Diageo PLC SPON ADR NEW | $49.6M | 666.3K | 0.6% | ▲+37% Added · +181K sh | |
| 39 | Aptiv PLC SHS | $47.5M | 683.5K | 0.6% | ▲+2.2% Added · +15K sh | |
| 40 | Vanguard Ftse Developed Markets ETF VAN FTSE DEV MKT | $47.2M | 736.6K | 0.6% | ▲+75% Added · +315K sh | |
| 41 | Dte Energy Co COM | $47.1M | 322.0K | 0.6% | ▲New New position | |
| 42 | BP PLC SPONSORED ADR | $46.9M | 997.9K | 0.6% | ▼−39% Reduced · −643K sh | |
| 43 | National Grid PLC SPONSORED ADR NE | $45.6M | 538.8K | 0.6% | ▼−24% Reduced · −171K sh | |
| 44 | Natwest Group PLC SPONS ADR | $44.5M | 2.99M | 0.5% | ▲+88% Added · +1.4M sh | |
| 45 | Joyy Inc ADS REPSTG COM A | $43.8M | 750.8K | 0.5% | ▼−7.6% Reduced · −62K sh | |
| 46 | Novo Nordisk A/s ADR | $43.2M | 1.17M | 0.5% | ▲+18% Added · +180K sh | |
| 47 | Pagseguro Digital Ltd COM CL A | $40.5M | 4.04M | 0.5% | ▼~0% Reduced · −1K sh | |
| 48 | Anheuser-Busch Inbev Sa SPONSORED ADR | $40.2M | 580.1K | 0.5% | ▼−17% Reduced · −121K sh | |
| 49 | ING Groep NV SPONSORED ADR | $40.1M | 1.54M | 0.5% | ▲+57% Added · +556K sh | |
| 50 | Texas Instruments Inc COM | $40.0M | 206.2K | 0.5% | ▲New New position |
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q1 2026 | Mar 31, 2026 | May 14, 2026 | 107 | $8.1B | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 13, 2026 | 108 | $7.3B | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 13, 2025 | 105 | $7.6B | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 13, 2025 | 99 | $6.3B | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 14, 2025 | 90 | $4.8B | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 13, 2025 | 107 | $4.4B | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 13, 2024 | 97 | $4.1B | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Aug 13, 2024 | 90 | $3.7B | 13F-HR |
| Q1 2024 | Mar 31, 2024 | May 15, 2024 | 89 | $3.8B | 13F-HR |
| Q4 2023 | Dec 31, 2023 | Feb 14, 2024 | 89 | $3.9B | 13F-HR |
| Q3 2023 | Sep 30, 2023 | Nov 13, 2023 | 89 | $3.8B | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Aug 11, 2023 | 81 | $3.8B | 13F-HR |
| Q1 2023 | Mar 31, 2023 | May 12, 2023 | 81 | $4.2B | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Feb 13, 2023 | 83 | $3.4B | 13F-HR |
| Q3 2022 | Sep 30, 2022 | Nov 14, 2022 | 81 | $3.6B | 13F-HR |
| Q2 2022 | Jun 30, 2022 | Aug 15, 2022 | 80 | $4.0B | 13F-HR |
| Q1 2022 | Mar 31, 2022 | May 13, 2022 | 75 | $4.2B | 13F-HR |
| Q4 2021 | Dec 31, 2021 | Feb 11, 2022 | 82 | $4.5B | 13F-HR |
| Q3 2021 | Sep 30, 2021 | Nov 12, 2021 | 81 | $4.4B | 13F-HR |
| Q2 2021 | Jun 30, 2021 | Aug 13, 2021 | 78 | $4.9B | 13F-HR |
| Q1 2021 | Mar 31, 2021 | May 14, 2021 | 82 | $5.1B | 13F-HR |
| Q4 2020 | Dec 31, 2020 | Feb 12, 2021 | 80 | $5.3B | 13F-HR |
| Q3 2020 | Sep 30, 2020 | Nov 13, 2020 | 79 | $5.4B | 13F-HR |
| Q2 2020 | Jun 30, 2020 | Aug 14, 2020 | 79 | $5.6B | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.